WS13.3 Tobacco smoke exposure limits the benefit of Symdeko® in paediatric cystic fibrosis patients: Cystic Fibrosis Foundation Patient Registry analysis
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽
Vol 19
(5)
◽
pp. 783-790
◽
Keyword(s):
2006 ◽
Vol 2006
◽
pp. 55-57
Keyword(s):